Literature DB >> 26605324

Adoptive T cell therapy for the treatment of viral infections.

Reuben J Arasaratnam1, Ann M Leen1.   

Abstract

Entities:  

Year:  2015        PMID： 26605324      PMCID： PMC4630547          DOI： 10.3978/j.issn.2305-5839.2015.10.12

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  39 in total

Review 1.  Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.

Authors:  John R Wingard; Jack Hsu; John W Hiemenz
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

Review 2.  Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection.

Authors:  Thomas Jacobsen; Nicole Sifontis
Journal:  Am J Health Syst Pharm       Date:  2010-09-01       Impact factor: 2.637

Review 3.  Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Authors:  Anna L Taylor; Christopher J E Watson; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

4.  Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation.

Authors:  Emily Blyth; Leighton Clancy; Renee Simms; Chun K K Ma; Jane Burgess; Shivashni Deo; Karen Byth; Ming-Celine Dubosq; Peter J Shaw; Kenneth P Micklethwaite; David J Gottlieb
Journal:  Blood       Date:  2013-02-22       Impact factor: 22.113

Review 5.  Emerging viruses in transplantation.

Authors:  Deepali Kumar
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

6.  Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.

Authors:  Ekaterina Doubrovina; Banu Oflaz-Sozmen; Susan E Prockop; Nancy A Kernan; Sara Abramson; Julie Teruya-Feldstein; Cyrus Hedvat; Joanne F Chou; Glenn Heller; Juliet N Barker; Farid Boulad; Hugo Castro-Malaspina; Diane George; Ann Jakubowski; Guenther Koehne; Esperanza B Papadopoulos; Andromachi Scaradavou; Trudy N Small; Ramzi Khalaf; James W Young; Richard J O'Reilly
Journal:  Blood       Date:  2011-12-02       Impact factor: 22.113

7.  Chronic kidney disease after nonrenal solid-organ transplantation.

Authors:  Roy D Bloom; Peter P Reese
Journal:  J Am Soc Nephrol       Date:  2007-12       Impact factor: 10.121

Review 8.  Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.

Authors:  Ajit P Limaye
Journal:  Semin Respir Infect       Date:  2002-12

9.  Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

Authors:  Biagio De Angelis; Gianpietro Dotti; Concetta Quintarelli; Leslie E Huye; Lan Zhang; Ming Zhang; Fabrizio Pane; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Barbara Savoldo
Journal:  Blood       Date:  2009-09-16       Impact factor: 22.113

10.  The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation.

Authors:  C Y William Tong; Ali Bakran; J S Malik Peiris; Peter Muir; C Simon Herrington
Journal:  Transplantation       Date:  2002-08-27       Impact factor: 4.939
View more
  7 in total

Review 1.  How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation.

Authors:  Alpana Waghmare; Janet A Englund; Michael Boeckh
Journal:  Blood       Date:  2016-03-11       Impact factor: 22.113

2.  Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy.

Authors:  Caroline Mangare; Sabine Tischer-Zimmermann; Agnes Bonifacius; Sebastian B Riese; Anna Christina Dragon; Rainer Blasczyk; Britta Maecker-Kolhoff; Britta Eiz-Vesper
Journal:  Transfus Med Hemother       Date:  2021-09-10       Impact factor: 3.747

Review 3.  Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients.

Authors:  Sandesh Parajuli; Margaret Jorgenson; Ross O Meyers; Arjang Djamali; Jacques Galipeau
Journal:  Kidney360       Date:  2021-03-26

Review 4.  Infectious disease risks in pediatric renal transplantation.

Authors:  Felicia A Scaggs Huang; Lara Danziger-Isakov
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.651

5.  Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers.

Authors:  H F Moffett; M E Coon; S Radtke; S B Stephan; L McKnight; A Lambert; B L Stoddard; H P Kiem; M T Stephan
Journal:  Nat Commun       Date:  2017-08-30       Impact factor: 14.919

6.  Intestinal Adenovirus Shedding Before Allogeneic Stem Cell Transplantation Is a Risk Factor for Invasive Infection Post-transplant.

Authors:  Karin Kosulin; Bettina Berkowitsch; Susanne Matthes; Herbert Pichler; Anita Lawitschka; Ulrike Pötschger; Gerhard Fritsch; Thomas Lion
Journal:  EBioMedicine       Date:  2018-01-09       Impact factor: 8.143

7.  High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?

Authors:  Nele Carolin Heinemann; Sabine Tischer-Zimmermann; Torge Christian Wittke; Julian Eigendorf; Arno Kerling; Theodor Framke; Anette Melk; Hans-Gert Heuft; Rainer Blasczyk; Britta Maecker-Kolhoff; Britta Eiz-Vesper
Journal:  J Transl Med       Date:  2020-04-01       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.